CytomX Therapeutics (CTMX) Long-Term Investments (2016 - 2021)
CytomX Therapeutics (CTMX) reported Long-Term Investments of $100.0 million for Q3 2021, little changed quarter-over-quarter from $99.9 million in Q2 2021.
CytomX Therapeutics (CTMX) Long-Term Investments (2016 - 2021) Analysis & Trends
CytomX Therapeutics has reported Long-Term Investments for 2 years, with the latest figure at $100.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 99.97 Mn |
| Jun 30, 2021 | 99.91 Mn |
| Sep 30, 2016 | 2.03 Mn |